Medication info
Omekra Tablet 375 mg (Amoxicillin Trihydrate · Clavulanate Potassium (2:1))

Omekra Tablet 375 mg (Amoxicillin Trihydrate · Clavulanate Potassium (2:1))

Prescription medicationTabletOral
Ingredient · strength
Amoxicillin Hydrate›250mg / 1 tabletDilute Potassium Clavulanate›212.73mg / 1 tablet
Manufacturer / importer
Austin Pharmaceuticals Co., Ltd.
Appearance
White or nearly white oval film-coated tablet
Packaging
80 tablets (8 tablets/PTP × 10)
Approval status
Active

MFDS item code 201307113 · Approved 2013.04.29 · Insurance code 654304750

Summary

Main use
Treatment of respiratory and ear, nose, and throat infections, skin, bone, and dental infections, and genitourinary infections
Who takes it
Adults · Children
Adult dose
The dose of this medicine should be determined based on the patient's age, body weight, renal function, and the severity of the infection. Administer at the start of a meal to minimize potential gastrointestinal intolerance. Absorption of amoxicillin/clavulanate is optimized when administered at the start of a meal. Adults: Administer amoxicillin/potassium clavulanate 250 mg/125 mg orally per dose 3 times daily, every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to amoxicillin/potassium clavulanate 500 mg/125 mg per dose. In patients with renal impairment, adjust the dose appropriately according to creatinine clearance. Adults: Dose adjustment is based on the maximum recommended dose of amoxicillin. No dose adjustment is necessary in patients with a creatinine clearance (CrCl) of 30 mL/min or greater. 10 ~ 30 mL/min Administer amoxicillin/potassium clavulanate 250mg/125mg or amoxicillin/potassium clavulanate 500mg/125mg per dose every 12 hours. 10 mL/min or less Administer amoxicillin/potassium clavulanate 250mg/125mg or amoxicillin/potassium clavulanate 500mg/125mg per dose every 24 hours. Hemodialysis Administer amoxicillin/potassium clavulanate 250mg/125mg or amoxicillin/potassium clavulanate 500mg/125mg per dose every 24 hours, with an additional dose during dialysis and a repeat dose at the end of dialysis. (Because serum concentrations of both amoxicillin and clavulanate decrease)
Child dose
Children aged 12 years or older or weighing 40 kg or more: Administer 250 mg/125 mg of amoxicillin/potassium clavulanate orally 3 times daily, every 8 hours. For severe infections and respiratory infections, the dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose. Children: Reduce the dose in the same manner.

Ingredients

Manufacturer
Austin Pharmaceuticals Co., Ltd.

Efficacy & effects

Treatment of respiratory and ear, nose, and throat infections, skin, bone, and dental infections, and genitourinary infections

  • Acute and chronic bronchitis
  • lobar pneumonia
  • bronchopneumonia
  • empyema
  • lung abscess
  • tonsillitis
  • sinusitis
  • otitis media
  • cystitis
  • urethritis
  • pyelonephritis
  • pelvic infections
View approved original text

This medication is effective in treating various bacterial infections. It is used for respiratory infections including acute and chronic bronchitis, pneumonia, sinusitis, and otitis media, as well as urinary tract infections such as cystitis, urethritis, and pyelonephritis. It is also suitable for the treatment of pelvic infections and sexually transmitted diseases such as gonorrhea. It can be utilized for various skin infections, including skin and soft tissue infections, abscesses, and osteomyelitis. It is also helpful in treating dental infections, making it applicable in the treatment of extensive infectious diseases.

How to take

Adult dose

The dose of this medicine should be determined based on the patient's age, body weight, renal function, and the severity of the infection. Administer at the start of a meal to minimize potential gastrointestinal intolerance. Absorption of amoxicillin/clavulanate is optimized when administered at the start of a meal. Adults: Administer amoxicillin/potassium clavulanate 250 mg/125 mg orally per dose 3 times daily, every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to amoxicillin/potassium clavulanate 500 mg/125 mg per dose. In patients with renal impairment, adjust the dose appropriately according to creatinine clearance. Adults: Dose adjustment is based on the maximum recommended dose of amoxicillin. No dose adjustment is necessary in patients with a creatinine clearance (CrCl) of 30 mL/min or greater. 10 ~ 30 mL/min Administer amoxicillin/potassium clavulanate 250mg/125mg or amoxicillin/potassium clavulanate 500mg/125mg per dose every 12 hours. 10 mL/min or less Administer amoxicillin/potassium clavulanate 250mg/125mg or amoxicillin/potassium clavulanate 500mg/125mg per dose every 24 hours. Hemodialysis Administer amoxicillin/potassium clavulanate 250mg/125mg or amoxicillin/potassium clavulanate 500mg/125mg per dose every 24 hours, with an additional dose during dialysis and a repeat dose at the end of dialysis. (Because serum concentrations of both amoxicillin and clavulanate decrease)

Child dose

Children aged 12 years or older or weighing 40 kg or more: Administer 250 mg/125 mg of amoxicillin/potassium clavulanate orally 3 times daily, every 8 hours. For severe infections and respiratory infections, the dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose. Children: Reduce the dose in the same manner.

Precautions

This medication is a penicillin-type antibiotic and should not be administered to patients with a history of specific allergic reactions. Patients with previous hypersensitivity reactions to beta-lactam antibiotics or those with infectious mononucleosis or lymphocytic leukemia are at increased risk of rash and should be cautious. Patients with a history of liver dysfunction or jaundice may also experience recurrence of symptoms when using this medication. Patients with impaired liver or kidney function may have increased drug concentration, thus requiring adjustments to the dosing interval. Caution is advised for patients with allergic predispositions or poor nutritional states, the elderly, and those with gastrointestinal disorders accompanied by vomiting or diarrhea. This medication may cause gastrointestinal side effects such as diarrhea, vomiting, abdominal pain, and, rarely, serious symptoms like pseudomembranous colitis or acute pancreatitis can occur. Symptoms suggesting liver dysfunction have also been reported, so especially the elderly or those on long-term therapy should have liver function tests. Serious skin reactions, including rash, itching, and severe cases like Stevens-Johnson syndrome, may occur, necessitating immediate medical attention upon symptom onset. Changes such as leukopenia, anemia, and thrombocytopenia may appear on blood tests, so regular blood tests are recommended. Central nervous system-related symptoms such as anxiety, dizziness, and seizures have been reported, although infrequently, and caution is necessary for patients with kidney impairment. Patients with reduced kidney function may present acute renal failure or hematuria, thus requiring periodic monitoring. This medication may disrupt the intestinal bacterial balance, potentially leading to fungal infections such as candidiasis. The risk of bleeding tendencies due to vitamin K deficiency may occur, so caution regarding bleeding symptoms is essential. If this medication is taken for an extended period, regular tests for kidney, liver, and hematopoietic function are necessary. Especially in cases with a history of hypersensitivity to penicillin or other beta-lactam antibiotics, consultation with a physician before use is mandatory. Use during the first three months of pregnancy is to be avoided, and pregnant or nursing women should carefully evaluate the benefits and risks of using this medication. If nursing mothers take this medication, monitoring for diarrhea or skin rashes in infants is necessary. It is not recommended for children under 12 years or weighing less than 40 kg due to limited usage experience. The elderly may experience a greater likelihood of adverse reactions due to decreased physiological function, thus requiring careful adjustment of dosage and dosing intervals. This medication may interact with other drugs, particularly anticoagulants or specific antibiotics, so strict adherence to a physician's directions is required when used in combination. In case of overdose, gastrointestinal symptoms and central nervous system anomalies may occur, necessitating immediate treatment, including possible hemodialysis if required. This medication should be stored in a cool, dry place below 25 degrees Celsius, and it is important to take it exactly as prescribed by a physician.

Side effects

Diarrhea, pseudomembranous colitis, dyspepsia, stomatitis, gastritis, glossitis, black hairy tongue, nausea, vomiting, loss of appetite, abdominal pain, abdominal bloating, constipation, colonic pain, hyperacidity, soft stools, xerostomia, acute pancreatitis, candidiasis, antibiotic-induced colitis, severe colitis with bloody stools, increased AST, increased ALT, increased ALP, increased LDH, elevated serum bilirubin, hepatitis, cholestatic jaundice, itching, erythema multiforme, mucocutaneous syndrome, toxic epidermal necrolysis, vesiculobullous dermatitis, acute generalized exanthematous pustulosis, drug reaction with eosinophilia and systemic symptoms, angioedema, anaphylaxis, serum sickness syndrome, hypersensitivity vasculitis, respiratory distress with bronchospasm, laryngeal edema, anaphylactic shock, reversible leukopenia, reversible thrombocytopenia, hemolytic anemia, anemia, thrombocytopenic purpura, eosinophilia, leukemia, agranulocytosis, lymphopenia, thrombocytosis, bone marrow suppression, prolonged bleeding time, prolonged prothrombin time, mucosal candidiasis, vaginal itching, vaginal burning, increased discharge, agitation, anxiety, behavioral changes, confusion, drowsiness, insomnia, reversible hyperactivity, dizziness, headache, seizures, antidystonic, fever, altered consciousness, aseptic meningitis, acute renal failure, interstitial nephritis, hematuria, crystalluria, vitamin K deficiency symptoms, vitamin B complex deficiency symptoms, linear IgA disease, taste disturbance, malaise, dermatitis, oral edema, gastric pain, fluid and electrolyte imbalance, rash, hyperactivity, drowsiness, renal failure, interstitial encephalopathy, hypersensitivity shock, skin reaction, bleeding, pancytopenia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent moisture, in a cool, dry place below 25 degrees Celsius. Proper storage will help maintain the medication's efficacy over time.

Appearance and packaging

Appearance

White or nearly white oval film-coated tablet

Package unit

80 tablets (8 tablets/PTP × 10)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.